Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.83B Activated in VL: True Average Daily Range Avg Daily Range: $1.62 | 3.52% Avg Daily Range (30 D): $0.90 | 4.79% Avg Daily Range (90 D): $0.94 | 3.94% Institutional Daily Volume Avg Daily Volume: .86M Avg Daily Volume (30 D): 2.28M Avg Daily Volume (90 D): 1.59M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 2,882 Avg Inst. Trade: $3.16M Avg Inst. Trade (30 D): $2.99M Avg Inst. Trade (90 D): $2.98M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.89M Avg Closing Trade (30 D): $5.22M Avg Closing Trade (90 D): $5.6M Avg Closing Volume: 128.34K         News Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Feb 24, 2025 @ 12:00 PM Beam Therapeutics to Participate in Upcoming March... Source: N/A Jan 30, 2025 @ 12:00 PM Beam Therapeutics to Participate in Guggenheim SMI... Source: N/A Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Dec 8, 2024 @ 6:45 PM Beam Therapeutics Presents New Non-human Primate (... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-4.58 $-1.09 $-4.58 Diluted EPS $-4.58 $-1.09 $-4.58 Revenue $ 63.52M $ 30.07M $ 63.52M Gross Profit $ $ $ Net Income / Loss $ -376.74M $ -90.35M $ -376.74M Operating Income / Loss $ -415.57M $ -100.04M $ -415.57M Cost of Revenue $ $ $ Net Cash Flow $ -154.5M $ 53.36M $ -154.5M PE Ratio